Celsus, Inc., a closely-held enterprise, was founded in 1987 to manufacture derivatives of crude heparin and to pursue the development of related complex carbohydrates belonging to the family of sulfated glycosaminoglycans for unmet medical and biomedical needs. The Company's tradename evokes the name of Aulus Cornelius Celsus, a first-century Roman medical encyclopedist.
